Assembly Biosciences Inc. (ASMB), a biotechnology company, on Friday reported pricing of its underwritten registered offering.The company is offering 3,358,602 shares of common stock at $2.65 per share.
In lieu of shares, the company is offering certain investors pre-funded warrants to purchase up to 415,000 shares at an exercisable rate of $0.001 per share.
Additionally, Assembly is offering underwriters a 30-day option to purchase an additional 566,040 shares of common stock, at the same price of the public offering.
The proceeds from the offering are estimated to be $100 million and are expected to be used in developing the company's pipeline candidates, and for general corporate purposes.
The offering will close on or before May 26, 2026.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.